Synthon Pharmaceuticals' paroxetine mesylate [Pexeva] is to be available in the US this month

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1432-1433, 2004-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paroxetine mesylate: comparable to paroxetine hydrochloride?

By Pae Chi-Un Misra Aayushman Ham Byung-Joo Han Changsu Patkar Ashwin A Masand Prakash S

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 185-193

Informa Healthcare

Access to resources Recommend Favorite

Persistent benefits of slow titration of paroxetine in a six‐month follow‐up

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 5, 2015-09 ,pp. : 329-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

The prices of several pharmaceuticals have been increased in Hungary this month

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The US FDA has recommended that paroxetine [`Paxil'] not be used in children and adolescents

Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Tianeptine in Major Depression: Evidence from a 3-Month Controlled Clinical Trial versus Paroxetine

By Waintraub L.

CNS Drugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 65-75

Adis International

Access to resources Recommend Favorite